R Nilius
About
In The Last Decade
R Nilius
29 papers receiving 325 citations
Peers
Comparison fields: 5 of 60
- Hepatology 242
- Epidemiology 221
- Surgery 117
- Clinical Biochemistry 43
- Pharmacology 33
Countries citing papers authored by R Nilius
This map shows the geographic impact of R Nilius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Nilius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Nilius more than expected).
Fields of papers citing papers by R Nilius
This network shows the impact of papers produced by R Nilius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Nilius. The network helps show where R Nilius may publish in the future.
Co-authorship network of co-authors of R Nilius
This figure shows the co-authorship network connecting the top 25 collaborators of R Nilius. A scholar is included among the top collaborators of R Nilius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Nilius. R Nilius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 227 | |
| 4 | Changes of dipeptidylpeptidase IV as a membrane marker of lymphocytes in acute and chronic liver diseases--biochemical and cytochemical investigations. | 11 |
| 5 | Hepatic aldehyde dehydrogenase (E.C. 1.2.1.3.) isoenzymes and malondialdehyde levels in alcoholic liver disease. | 2 |
| 6 | 28 | |
| 7 | [Thromboembolism risk factors in kidney transplant patients with secondary erythrocytosis in relation to hemorheologic aspects]. | 3 |
| 8 | Immunoglobulin allotypes and immunoreactivity in chronic liver disease. | 4 |
| 9 | [Adenosine deaminase activity--an indicator of inflammation in liver disease]. | 4 |
| 10 | New aspects in aetiology and pathogenesis of liver diseases | 2 |
| 11 | Haptoglobin type and liver disease. | 4 |
| 12 | [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases]. | 1 |
| 13 | Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial. | 6 |
| 14 | [Cell-mediated immune reactivity in skin tests in chronic liver diseases]. | 1 |
| 15 | [Alkaline phosphatase isoenzymes and hyperthyroidism]. | 1 |
| 16 | [Multivariant discriminance analytical computation methods for the evaluation of clinico-chemical parameters in liver and biliary tract diseases]. | 1 |
| 17 | [Studies on the functional ability of swine liver perfused with human blood in machine recirculation attempt. Experiment design, elimination of indocyanine green, galactose, bilirubin and ammonia, synthesis of urea, bile secretion]. | 1 |
| 18 | [Aminopeptidases in the serum following myocardial infarct]. | 1 |
| 19 | [The serum beta-glucuronidase in liver diseases]. | 1 |
| 20 | [On the determination of beta-glucuronidase in serum]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.